Aminohippurate Sodium Pah

Aminohippurate Sodium Pah

Aminohippurate Sodium Pah Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Estimation of effective renal plasma flow.

Measurement of the functional capacity of the renal tubular secretory mechanism.

History

There is currently no drug history available for this drug.

Other Information

Aminohippurate sodium1 is an agent to measure effective renal plasma flow (ERPF). It is the sodium salt of para-aminohippuric acid, commonly abbreviated “PAH”. It is water soluble, lipid-insoluble, and has a pKa of 3.83. The empirical formula of the anhydrous salt is C9H9N2NaO3 and its structural formula is:

Image of Chemical Structure

It is provided as a sterile, non-preserved 20 percent aqueous solution for injection, with a pH of 6.7 to 7.6. Each 10 mL contains: Aminohippurate sodium 2 g. Inactive ingredients: Sodium hydroxide to adjust pH, water for injection, q.s.

1

Formerly referred to as Sodium para-Aminohippurate.

Aminohippurate Sodium Pah Manufacturers


  • Merck Sharp & Dohme Corp.
    Aminohippurate Sodium Pah (Aminohippurate Sodium) Injection, Solution [Merck Sharp & Dohme Corp.]

Login To Your Free Account